08/12/2025
💚 Today, Merry visited us for her scheduled Librela injection, a monoclonal antibody treatment aimed at managing her arthritis pain.
We understand that recently published information regarding potential adverse effects of Librela has been a topic of debate and concern. We want to assure all of Merry's followers and owners considering this treatment that the decision to continue with Librela was made only after careful and thorough consideration of Merry's specific health needs and history.
Merry, like many dogs, unfortunately experiences gastrointestinal side effects, specifically diarrhoea, when on conventional non-steroidal anti-inflammatory drugs (NSAIDs). Other pain relief options we explored previously did not offer her sufficient comfort or quality of life. For Merry, Librela has proven to be the most effective treatment for managing her chronic pain and keeping her comfortable and happy.
Our priority is always Merry's well-being and quality of life. We are closely monitoring her progress and health, and will continue to work with her owners to ensure the best possible care plan is in place for her golden years.
If you have any questions about arthritis management or treatment options for your pet, please reach out to us for a consultation. We believe in tailoring treatment plans to each individual animal’s needs and health profile 💚